quarter

Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses

AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in the second quarter of FY26,…

1 month ago

Nava Delivers Strong Operational Growth And Strategic Advancements; Strengthens Dividend Momentum

HYDERABAD, India, Nov. 7, 2025 /PRNewswire/ -- Nava Limited, a diversified Indian multinational with interests spanning Metals, Mining, Energy, Commercial…

1 month ago

Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter…

1 month ago

uniQure to Announce Third Quarter 2025 Financial Results

LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing…

1 month ago

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…

1 month ago

NEXEN TIRE Achieves KRW 780.7 Billion in Sales, 10% YoY Growth in Q3 2025

Sales growth driven by launching region-specific products, expanding the distribution network, and strengthening domestic rental salesImproving quarter-on-quarter profitability through cost…

1 month ago

Automobili Lamborghini confirms its solidity over the first nine months of 2025

Resilient results in a complex global environment demonstrate the strength of the company’s financial model and the confidence in its…

1 month ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

2 months ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

2 months ago

AMSC to Report Second Quarter Fiscal Year 2025 Financial Results on November 5, 2025

October 31, 2025 16:33 ET  | Source: AMSC AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC® (NASDAQ: AMSC), a…

2 months ago